Cite

HARVARD Citation

    Kramer, J. et al. (n.d.). Investigators' Experience With Expedited Safety Reports Prior to the FDA's Final IND Safety Reporting Rule. Therapeutic innovation & regulatory science. pp. 413-419. [Online]. 
  
Back to record